Timothy Coté

Last updated
  1. 1 2 "Archived copy" (PDF). csdd.tufts.edu. Archived from the original (PDF) on 11 June 2010. Retrieved 17 January 2022.{{cite web}}: CS1 maint: archived copy as title (link)
  2. 1 2 3 4 Commissioner, Office of the. "2007 - FDA Appoints Coté to Head Orphan Products Development Office". Food and Drug Administration .
  3. 1 2 "Former FDA Official Tim Cote JoinsEmmaus Medical Inc as Regulatory Advisor".
  4. "Search Orphan Drug Designations and Approvals".
  5. Torres, Christian (1 March 2010). "Rare opportunities appear on the horizon to treat rare diseases". Nat Med. 16 (3): 241. doi:10.1038/nm0310-241. PMID   20208483. S2CID   1332461.
  6. Coté, Timothy R.; Xu, Kui; Pariser, Anne R. (1 December 2010). "Accelerating orphan drug development". Nat Rev Drug Discov. 9 (12): 901–902. doi:10.1038/nrd3340. PMID   21119719. S2CID   43668080.
  7. Xu, Kui; Coté, Timothy R. (1 July 2011). "Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases". Brief Bioinform. 12 (4): 341–345. doi:10.1093/bib/bbr006. PMID   21357612 via bib.oxfordjournals.org.
  8. "Cote named as FDA director of orphan product development". Archived from the original on 2016-08-13. Retrieved 2016-06-23.
  9. "Meeting Our Nation's Important Public Health Challenges: Transformation of the Public Health Service Commissioned Corps, Testimony Before the Committee on Government Reform, October 30, 2003". Archived from the original on August 28, 2016. Retrieved June 23, 2016.
  10. "#PhRMA12 Conversations: Dr. Tim Cote - PhRMA".
  11. "Since July 2011, Timothy Cote MD MPH has served half the time as the Chief Medical Officer for the National Organization for Rare Disorders (NORD) and the other half as Professor of Regulatory Practice for the Keck Graduate Institute (KGI) in Claremont, California. Prior to these appointments he was Director of FDA's Office of Orphan Products Development for four years. - Image - Pharmaceutical Technology".
  12. "Home". Archived from the original on 2016-07-06. Retrieved 2016-06-23.
  13. "Coté Orphan Consulting Reviews".
  14. "Coté Orphan, a QuintilesIMS company". LinkedIn.
  15. "Timothy Cote - Independent Entrepreneur - Self Employed | LinkedIn".
Timothy R. Coté
Tim linkedin.jpg
Director of the Office of Orphan Products Development
In office
September 2007 June 2011